NCT03560544 is a NA clinical trial of Breaking up sitting in Sedentary Lifestyle, sponsored by University of Bedfordshire.

Who is sponsoring NCT03560544?

NCT03560544 is sponsored by University of Bedfordshire.

What drugs are being tested in NCT03560544?

Interventions in NCT03560544: Breaking up sitting.

What condition does NCT03560544 study?

NCT03560544 studies Sedentary Lifestyle.

Is NCT03560544 still recruiting?

NCT03560544 is currently status unknown. Last updated 10 October 2018.

Last reviewed 2018-10-10 · How we verify

NCT03560544

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Breaking up Sitting in the Workplace on Cardiometabolic Risk and Worker Productivity

Status unknown NA Last updated 10 October 2018

What this trial tests

NA trial testing Breaking up sitting in Sedentary Lifestyle in 46 participants. Status unknown.

Timeline

25 June 2018

Primary endpoint
30 September 2018

31 December 2018

Quick facts

Lead sponsor	University of Bedfordshire
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	46
Start date	25 June 2018
Primary completion	30 September 2018
Estimated completion	31 December 2018
Sites	2 locations across United Kingdom

Drugs / interventions tested

Breaking up sitting

Conditions studied

Sedentary Lifestyle — all drugs for Sedentary Lifestyle →

Sponsor

University of Bedfordshire

Who can join

Adults 18 to 60, any sex, with Sedentary Lifestyle. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot randomized controlled trial (RCT) will examine the effect of a tailored workplace intervention based on interrupting sitting on work productivity, well-being and cardio-metabolic risk in office workers. The experimental group in the 8-week intervention will be prompted to alternate between sitting and standing while working. The ratio between sitting and standing will begin at 3:1 (two hours per day in an eight-hour day) and increase to 1:1 (four hours per day in an eight-hour day) by the end of the second week of the eight-week intervention.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Work-break schedules for preventing musculoskeletal symptoms and disorders in healthy workers.
Luger T, Maher CG, Rieger MA, Steinhilber B. · · 2019 · cited 46× · PMID 31334564 · DOI 10.1002/14651858.cd012886.pub2
Evaluating a multi-component intervention to reduce and break up office workers' sitting with sit-stand desks using the APEASE criteria.
Brierley ML, Smith LR, Bailey DP, Ojo SO, et al · · 2022 · cited 12× · PMID 35255850 · DOI 10.1186/s12889-022-12794-w
Workplace Intervention for Reducing Sitting Time in Sedentary Workers: Protocol for a Pilot Study Using the Behavior Change Wheel.
Ojo SO, Bailey DP, Chater AM, Hewson DJ. · · 2022 · cited 5× · PMID 35493386 · DOI 10.3389/fpubh.2022.832374

Verify or expand the search:

Other recruiting trials for Sedentary Lifestyle

Currently open trials in the same condition.

NCT03511352 — Sedentary Behavior Interrupted: A Trial of Acute Effects on Biomarkers of Healthy Aging · NA · active not recruiting
NCT03356262 — The QUebec Adipose and Lifestyle InvesTigation in Youth (QUALITY) Cohort · active not recruiting

Other University of Bedfordshire trials

Trials by the same sponsor.

NCT05771610 — SB and Cardiac Function and Structure in IHD · unknown
NCT05193175 — Effects of Breaking up Sitting Time on Cardiometabolic Risk Markers and Cardiac Function Post Myocardial Infarction · NA · unknown
NCT04645875 — Substituting Sitting With Standing and Walking in Free-living Conditions Improves Daily Glucose Profile in South Asians · NA · completed
NCT04053686 — An Intervention to Reduce Prolonged Sitting in Police Staff · NA · completed
NCT03898206 — Effects of Breaking up Prolonged Sitting on Postprandial Cardiometabolic Disease Risk Markers in South Asian Adults · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03560544 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Bedfordshire
Last refreshed: 10 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03560544.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing